Terms: = Cervical cancer AND MET, RCCP2, 4233, ENSG00000105976, P08581, HGFR, AUTS9 AND Clinical Outcome
12 results:
1. Is SBRT Boost Feasible for PET Positive Lymph Nodes for cervical cancer? Evaluation using Tumor Control Probability and QUANTEC Criteria.
Snyder JE; Willett AB; Sun W; Kim Y
Pract Radiat Oncol; 2019 Mar; 9(2):e156-e163. PubMed ID: 30415074
[TBL] [Abstract] [Full Text] [Related]
2. Do fertile women have an inferior treatment for high-grade precancerous lesions?
Kim M; Cho HY; Lee J; Suh DH; Kim K; No JH; Kim YB
J Obstet Gynaecol Res; 2018 Apr; 44(4):772-777. PubMed ID: 29369475
[TBL] [Abstract] [Full Text] [Related]
3. Occult invasive cervical cancer after simple hysterectomy: a multi-center retrospective study of 89 cases.
Bai H; Cao D; Yuan F; Wang H; Chen J; Wang Y; Shen K; Zhang Z
BMC Cancer; 2016 Jul; 16():507. PubMed ID: 27439407
[TBL] [Abstract] [Full Text] [Related]
4. A meta-analysis on selective versus comprehensive neck dissection in oral squamous cell carcinoma patients with clinically node-positive neck.
Liang L; Zhang T; Kong Q; Liang J; Liao G
Oral Oncol; 2015 Dec; 51(12):1076-81. PubMed ID: 26500065
[TBL] [Abstract] [Full Text] [Related]
5. Genetic polymorphisms as predictive and prognostic biomarkers in gynecological cancers: a systematic review.
Diaz-Padilla I; Amir E; Marsh S; Liu G; Mackay H
Gynecol Oncol; 2012 Feb; 124(2):354-65. PubMed ID: 22063461
[TBL] [Abstract] [Full Text] [Related]
6. Gene profiling in Pap-cell smears of high-risk human papillomavirus-positive squamous cervical carcinoma.
Manavi M; Hudelist G; Fink-Retter A; Gschwandtler-Kaulich D; Pischinger K; Czerwenka K
Gynecol Oncol; 2007 May; 105(2):418-26. PubMed ID: 17306351
[TBL] [Abstract] [Full Text] [Related]
7. Tumor hypoxia and expression of c-met in cervical cancer.
Leo C; Horn LC; Einenkel J; Hentschel B; Höckel M
Gynecol Oncol; 2007 Jan; 104(1):181-5. PubMed ID: 16996116
[TBL] [Abstract] [Full Text] [Related]
8. cDNA array analysis of cytobrush-collected normal and malignant cervical epithelial cells: a feasibility study.
Hudelist G; Czerwenka K; Singer C; Pischinger K; Kubista E; Manavi M
Cancer Genet Cytogenet; 2005 Apr; 158(1):35-42. PubMed ID: 15771902
[TBL] [Abstract] [Full Text] [Related]
9. Overexpression of the c-met/HGF receptor and its prognostic significance in uterine cervix carcinomas.
Baykal C; Ayhan A; Al A; Yüce K; Ayhan A
Gynecol Oncol; 2003 Feb; 88(2):123-9. PubMed ID: 12586590
[TBL] [Abstract] [Full Text] [Related]
10. Predictors of outcome in small cell carcinoma of the cervix--a case series.
Straughn JM; Richter HE; Conner MG; Meleth S; Barnes MN
Gynecol Oncol; 2001 Nov; 83(2):216-20. PubMed ID: 11606074
[TBL] [Abstract] [Full Text] [Related]
11. cervical cancer and sexual lifestyle: a systematic review of health education interventions targeted at women.
Shepherd J; Peersman G; Weston R; Napuli I
Health Educ Res; 2000 Dec; 15(6):681-94. PubMed ID: 11142076
[TBL] [Abstract] [Full Text] [Related]
12. Interventions for encouraging sexual lifestyles and behaviours intended to prevent cervical cancer.
Shepherd J; Weston R; Peersman G; Napuli IZ
Cochrane Database Syst Rev; 2000; (2):CD001035. PubMed ID: 10796735
[TBL] [Abstract] [Full Text] [Related]
